First Trust Health Care AlphaDEX Fund Rating $106.80 -0.52 (-0.48%) Closing price 04:10 PM EasternExtended Trading$106.80 0.00 (0.00%) As of 05:35 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ratings Stock AnalysisChartDividendHoldingsOwnershipRatingsShort InterestBuy This Stock First Trust Health Care AlphaDEX Fund Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.FXH Aggregate RatingModerate Buy 2.62Holdings in FXH have an aggregate rating of Moderate Buy based on 472 analyst ratings issued in the past year covering 25 companies (51.9% of the portfolio).FXH Aggregate Price Target$106.80High Prediction$106.80Average Prediction$106.80Low Prediction$106.80Holdings in FXH have an aggregate price target of $106.80 and a range of $106.80 to $106.80 covering 25 companies (51.9% of the portfolio).FXH Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy1 Buy rating(s)Moderate Buy17 Moderate Buy rating(s)Hold7 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by First Trust Health Care AlphaDEX Fund Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 25 FXH Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings2.51%JAZZJazz Pharmaceuticals$126.13+1.4%4.7535 of 5 stars2.87$178.21 41.3%15Analyst Forecast2.43%REGNRegeneron Pharmaceuticals$579.61-1.3%4.8516 of 5 stars2.81$817.67 41.1%27Trending NewsAnalyst Forecast2.39%INSMInsmed$134.97+0.3%3.8825 of 5 stars2.94$132.57 -1.8%172.39%MRKMerck & Co., Inc.$83.24-1.0%4.997 of 5 stars2.35$107.44 29.1%20Positive News2.38%ZBHZimmer Biomet$105.05-1.6%4.7505 of 5 stars2.35$111.44 6.1%20Positive NewsDividend Announcement2.38%AVTRAvantor$13.25+0.4%4.5864 of 5 stars2.47$15.50 17.0%15Positive News2.37%UTHRUnited Therapeutics$307.24+0.6%4.9273 of 5 stars2.69$382.00 24.3%13News CoveragePositive NewsAnalyst Revision2.33%BIIBBiogen$132.65-2.7%4.839 of 5 stars2.34$185.74 40.0%32Positive News2.30%ELANElanco Animal Health$18.47-0.1%2.8656 of 5 stars2.78$17.33 -6.2%9High Trading Volume2.24%ACHCAcadia Healthcare$22.62+2.0%4.7499 of 5 stars2.69$40.77 80.3%132.14%CAHCardinal Health$149.57+0.2%4.977 of 5 stars2.80$165.93 10.9%15Positive News2.10%TEMTempus AI$73.66+0.6%2.0232 of 5 stars2.50$67.64 -8.2%122.05%UHSUniversal Health Services$181.43-0.5%4.98 of 5 stars2.21$214.77 18.4%14Positive NewsAnalyst Forecast2.01%JNJJohnson & Johnson$175.50-0.7%4.8738 of 5 stars2.65$176.29 0.4%20Positive NewsOptions Volume1.94%BMRNBioMarin Pharmaceutical$57.68-1.7%4.9963 of 5 stars2.72$93.17 61.5%25Positive News1.92%EXELExelixis$37.90-1.6%4.8767 of 5 stars2.52$44.06 16.2%23Positive NewsAnalyst Downgrade1.92%OGNOrganon & Co.$9.18-0.3%4.7966 of 5 stars2.50$18.00 96.2%6Positive News1.85%ALNYAlnylam Pharmaceuticals$452.33-0.4%4.1618 of 5 stars2.85$405.33 -10.4%26Positive News1.83%PFEPfizer$24.60-1.9%4.8797 of 5 stars2.39$28.12 14.3%18Trending News1.82%VEEVVeeva Systems$272.51-7.2%3.6986 of 5 stars2.54$294.58 8.1%26Trending NewsAnalyst ForecastHigh Trading Volume1.81%BSXBoston Scientific$105.78-0.1%4.7237 of 5 stars3.04$117.50 11.1%26Positive News1.74%HUMHumana$297.99+0.2%4.1632 of 5 stars2.30$283.29 -4.9%23Positive NewsDividend Announcement1.72%ABTAbbott Laboratories$131.47+0.0%4.977 of 5 stars2.91$144.47 9.9%22Positive News1.70%PODDInsulet$337.60+1.0%4.3946 of 5 stars2.89$332.71 -1.4%18Positive News1.64%HCAHCA Healthcare$407.55+0.6%4.6228 of 5 stars2.53$401.83 -1.4%17Positive NewsAnalyst Forecast This page (NYSEARCA:FXH) was last updated on 8/28/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredBREAKING: The House just passed 3 pro-crypto bills!THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here. Crypto 101 Media | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredElon’s BIGGEST warning yet?Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | SponsoredTake a look at this picture ...A strange investment secret — discovered just a few short weeks before this image was taken — correctly predic...Weiss Ratings | SponsoredThink you missed gold’s boom? Think againIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | SponsoredThis is my Christian duty“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding First Trust Health Care AlphaDEX Fund Please log in to your account or sign up in order to add this asset to your watchlist. Share First Trust Health Care AlphaDEX Fund With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access